Afatinib (A) plus cetuximab (C) in the treatment of patients (pts) with NSCLC: The story so far

E. Smit, J-C. Soria, Y. Y. Janjigian, H. J. M. Groen, W. Pao, E. Calvo, A. Gazzah, J. Fan, M. Ould-Kaci, L. Horn

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Number of pages2
JournalAnnals of Oncology
Volume28
Publication statusPublished - Apr-2017
EventEuropean Lung Cancer Conference (ELCC) - Geneva, Switzerland
Duration: 5-May-20178-May-2017

Cite this